搜索
Search
这是描述信息

Sustainable Development

/
/
ESG Rating And Honors

ESG Rating And Honors

Description:
Description:
Information

ESG Rating And Honors

  • August 2024               SynTao Green Finance ESG Rating for the second quarter of 2024: A-
  • August 2024               The 21st Century Vitality · ESG Corporate Governance Cases
  • July 2024                    MSCI ESG Ratings: AAA (The first and only Chinese company in the global pharmaceutical industry to receive the highest MSCI ESG AAA                                                rating, and the only company in the Chinese pharmaceutical industry to do so for two consecutive years)
  • July 2024                    2024 ESG Model Enterprise Award and 2024 ESG Outstanding Case Award at the Third International Green Zero-Carbon Festival
  • July 2024                    Included in the "Sustainability Yearbook 2024 (China Edition)" by S&P Global and recognized as Industry Mover
  • July 2024                    2024 Yinghua Awards for Chinese Listed Companies: Hong Kong Stock ESG Value Award
  • June 2024                   Wind ESG Rating: AA (Ranked second among domestic pharmaceutical peers as of now)
  • April 2024                    Sino-Securities ESG Rating: A
  • February 2024             CDP Climate Change Questionnaire: B
  • February 2024             Included in the "Sustainability Yearbook 2024" by S&P Global and recognized as Industry Mover
  • January 2024              Included in 2023 Easy-board ESG+8 Top 100 List
  • January 2024              Best ESG Award (Roadshow China & Excellence IR)
  • December 2023          The Sina Finance China ESG "Golden Awards" 2023 Excellent Enterprise for Environmental Responsibility
  • December 2023          The Sina Finance 2023 Pharmaceutical Industry Golden Kirin Award - the Most Socially Responsible Pharmaceutical Company
  • December 2023          2023 TOP 50 ESG Listed Companies in China’s Non-Financial Industry (China Corporate Governance Experts 50 Forum)
  • December 2023          Top 100 Wind Chinese Listed Companies in Best ESG Practice in 2023
  • November 2023          S&P Global ESG Score: 65 (Ranked among the top 5% of global participating pharmaceutical companies)
  • October 2023              CNI ESG Ratings: AAA (Ranked first among domestic pharmaceutical industry)
  • October 2023              The Top 20 Chinese Pharmaceutical Listed Companies in ESG Competitiveness in 2023 (Mid-cap Stocks)
  • August 2023                Top1 of CSR Survey Score of Pharmaceutical Enterprises of Southern Weekly in 2022
  • August 2023                CSI ESG Rating: AAA
  • July 2023                    MSCI ESG Ratings: AAA (The first and only Chinese company in the global pharmaceutical industry to receive the highest MSCI ESG AAA                                                rating)
  • May 2023                    Wind ESG Rating: AA (Ranked first among domestic pharmaceutical peers as at June 2024)
  • May 2023                    5th New Fortune Best Listed Company — Best ESG Practice Award
  • December 2022          CDP Climate Change Questionnaire: B-
  • December 2022          The Reputation List of China Listed Companies for 2022 — Most Socially Responsible Listed Company
  • December 2022          6th China IR Annual Awards — Best ESG Award
  • November 2022          S&P Global CSA Score: 42
  • November 2022         Top 1 of the Top 20 Chinese Pharmaceutical Listed Companies in ESG Competitiveness in 2022
  • October 2022             Top 10 Wind Chinese Hong Kong-listed Companies in ESG Ratings in 2022 — Healthcare Industry
  • September 2022        Top 10 Wind Chinese A-shares Listed Companies in ESG Ratings in 2022 — Healthcare Industry
  • March 2022                New Fortune — Best ESG Information Disclosure Award

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China    Tel: 0756-8135888    

©2021 Livzon  粤ICP备05025993号  Support:300.cn

Add: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China  

©2021 Livzon   粤ICP备05025993号  

 Support:300.cn